Missing/wrong data?
Log in to edit
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
scientific article published on April 21, 2012
Author/s
author: Michel Marre, Simon Heller, John Buse, Satish K Garg, Ann Marie Ocampo Francisco, Areti Philotheou
Work details
Publication date
April 1, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.